Research challenges link between inflammation and aging

New research published in Nature Aging is challenging and refining the scientific understanding of ‘inflammaging’—the concept that chronic low-grade inflammation is a universal driver of age-related diseases like dementia, diabetes, and heart disease.

A study involving four populations across three continents suggests that the link between inflammation and aging may not be as tight as previously assumed. The findings indicate that inflammatory patterns might be a byproduct of industrialized lifestyles rather than a fundamental biological certainty of the aging process itself. This has implications for how medical providers and insurance plans assess disease risk and market anti-inflammatory interventions.

In a related development, research highlights the role of the protein fibronectin in Alzheimer’s disease. Studies suggest that the APOE4 genetic risk factor may drive an overproduction of fibronectin around brain blood vessels. This buildup thickens the blood-brain barrier and traps amyloid in the brain. Notably, a Columbia University-led study found that APOE4 carriers with a specific fibronectin gene variant that prevents this buildup had a 71% lower risk of developing Alzheimer’s, marking fibronectin as a potential target for future treatments.